BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17316623)

  • 1. Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma.
    Sibold S; Roh V; Keogh A; Studer P; Tiffon C; Angst E; Vorburger SA; Weimann R; Candinas D; Stroka D
    FEBS Lett; 2007 Mar; 581(5):989-94. PubMed ID: 17316623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
    Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS
    Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
    Akiba J; Murakami Y; Noda M; Watari K; Ogasawara S; Yoshida T; Kawahara A; Sanada S; Yasumoto M; Yamaguchi R; Kage M; Kuwano M; Ono M; Yano H
    Cancer Lett; 2011 Nov; 310(1):25-34. PubMed ID: 21775055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
    Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
    Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
    Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC.
    Guo DD; Xie KF; Luo XJ
    Gene; 2020 May; 741():144552. PubMed ID: 32165297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3beta.
    Banz VM; Medová M; Keogh A; Furer C; Zimmer Y; Candinas D; Stroka D
    Biochim Biophys Acta; 2009 Oct; 1793(10):1597-603. PubMed ID: 19682504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells.
    Yan X; Chua MS; Sun H; So S
    Cancer Lett; 2008 Apr; 262(1):133-42. PubMed ID: 18207320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
    Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
    Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.
    Lu WJ; Chua MS; So SK
    Carcinogenesis; 2014 Apr; 35(4):915-22. PubMed ID: 24302615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
    Bogaerts E; Heindryckx F; Devisscher L; Paridaens A; Vandewynckel YP; Van den Bussche A; Verhelst X; Libbrecht L; van Grunsven LA; Geerts A; Van Vlierberghe H
    PLoS One; 2015; 10(3):e0119555. PubMed ID: 25793288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
    Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
    Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers.
    Cangul H
    BMC Genet; 2004 Sep; 5():27. PubMed ID: 15341671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
    Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
    Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
    Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
    J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of NDRG1 gene with liver tissue differentiation and hepatocarcinogenesis].
    He J; Zhou R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 35(5):471-5. PubMed ID: 14601301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors affecting expression of differentiation-related gene NDRG1].
    Zhang G; Bai S; Zou Y; Wang F
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):356-8. PubMed ID: 25030876
    [No Abstract]   [Full Text] [Related]  

  • 20. The anticancer effects of desferrioxamine on human breast adenocarcinoma and hepatocellular carcinoma cells.
    Salis O; Bedir A; Kilinc V; Alacam H; Gulten S; Okuyucu A
    Cancer Biomark; 2014; 14(6):419-26. PubMed ID: 25335733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.